Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 3—March 2025
Research Letter
Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola
Table 1
Resistance profiles of cases in study of multidrug-resistant tuberculosis, Luanda, Angola
Drug | No. (%) cases showing resistance, N = 474 |
---|---|
Rifampin | 38 (8.0) |
Isoniazid | 19 (4.0) |
Fluoroquinolones | 2 (0.4) |
Amikacin | 0 |
Ethionamide | 4 (0.8) |
Page created: February 04, 2025
Page updated: February 21, 2025
Page reviewed: February 21, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.